TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
PAHC

Phibro Animal Health Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

37.40$ -0.8% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Phibro Animal Health Corporation (PAHC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,501 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PAHC
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
598 592 602 623 671 663 671 672 678 697 706 727 795 788 776 784 790 804 805 841 836 849 916 932 948 962 965 971 965 973 979 982 966 1,286 1,317 1,361 1,386 1,406 1,445 1,501
340 339 348 364 395 396 407 415 420 441 452 466 456 445 438 452 464 477 472 499 499 509 546 566 570 582 585 586 584 587 597 601 571 746 776 811 836 862 894 936
37 39 49 56 62 40 31 29 26 31 36 58 55 26 27 36 31 35 49 50 41 63 71 74 76 68 37 41 43 33 50 71 52 67 60 68 73 55 55 61
37 39 49 56 62 67 76 79 76 80 85 82 79 75 82 91 92 96 93 93 97 95 93 91 86 78 77 81 91 92 99 115 90 67 70 77 85 75 77 82
120 124 113 126 136 132 127 136 135 144 153 159 145 147 152 127 125 126 136 147 141 142 157 167 143 152 153 163 149 151 161 169 161 192 198 228 218 216 222 239
163 159 164 161 171 174 184 178 186 193 190 198 204 194 177 197 206 213 206 216 221 231 250 259 281 289 293 278 279 287 282 266 273 427 448 444 472 517 540 535
127 127 127 127 131 128 127 130 131 133 135 140 142 145 143 171 147 150 150 188 153 155 162 165 179 186 189 196 – – – – – – – – – – – –
21 21 21 24 24 30 30 27 27 27 27 27 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 53 55 55 55 55 55 55 60 60 60 60 60
59 57 58 55 64 56 54 52 52 51 49 47 78 76 73 71 69 67 64 62 60 58 67 64 61 59 57 55 52 51 48 45 43 40 38 36 35 33 32 30
496 480 463 472 502 495 485 487 486 492 493 511 589 571 581 596 597 590 589 603 603 610 649 669 686 693 693 689 691 702 709 726 708 1,039 1,051 1,075 1,074 1,073 1,083 1,116
101 103 106 116 121 127 129 143 129 136 133 154 142 147 161 157 161 167 169 164 153 167 187 191 172 168 165 176 172 188 189 204 177 233 266 293 270 282 282 316
2.9 2.9 2.9 6.3 7.9 9.5 11 13 13 13 13 13 20 22 24 25 27 29 30 16 18 20 21 21 21 21 22 28 31 33 37 37 15 24 25 25 27 30 32 36
54 55 53 57 62 65 64 59 62 65 64 73 61 58 68 66 62 63 63 68 67 81 90 96 88 80 76 74 77 86 83 86 87 99 132 138 131 133 130 127
62 49 30 65 85 71 66 70 85 88 96 96 381 357 350 368 378 365 357 383 394 387 401 418 452 461 466 453 459 449 456 458 467 737 711 702 725 711 713 708
102 113 139 151 169 168 186 185 192 205 214 216 207 217 195 188 192 213 216 239 233 239 267 262 263 268 272 283 273 271 270 257 259 247 266 286 312 332 362 385
42 52 71 83 95 98 113 132 145 155 165 169 167 174 182 183 191 198 206 218 220 232 245 248 247 249 254 261 248 244 248 244 246 244 260 273 294 317 336 353
40 40 40 40 40 40 40 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41 41

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?